Brent Ness
Known title: Chief Executive OfficerCIK: 0001903562
Brent Ness's purchase track record
How the stock did after each of Brent Ness's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 4 since April 21, 2022
Stock higher 6 months later
33%
3 months: 25%
Median 6-month return
-49.7%
3 months: -40.3%
Beat the S&P 500
33%
median -53.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/11/2026 | ACON | $20K | -23.9% | pending | — |
| 11/26/2025 | ACON | $62 | -56.8% | -49.7% | +10.4% |
| 12/28/2022 | ACON | $10K | +73.8% | +63.1% | +15.7% |
| 4/21/2022 | ACON | $4K | -69.1% | -70.0% | -16.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ACON | ▲ Buy | Grant | 100,000 | $0 | 6/11/2026 | View on chart |
| ACON | ▲ Buy | Open Market | 6,289 | $20K | 5/11/2026 | View on chart |
| ACON | ▲ Buy | Open Market | 10 | $62 | 11/26/2025 | View on chart |
| ACON | ▲ Buy | Open Market | 8,500 | $4K | 12/29/2022 | View on chart |
| ACON | ▲ Buy | Open Market | 7,711 | $4K | 12/29/2022 | View on chart |
| ACON | ▲ Buy | Open Market | 2,289 | $961 | 12/28/2022 | View on chart |
| ACON | ▲ Buy | Open Market | 1,000 | $4K | 4/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
ACON Adds NYU Langone Health to CLARITY Trial Network
Aclarion Inc. announced that NYU Langone Health has joined its CLARITY Trial Network. The partnership brings the health system into 11 enrolling sites, expanding the company’s clinical trial footprint. This move could increase the pace of data collection for Aclarion’s pipeline. The announcement comes as the stock trades near its 14‑day support level.
ACON Adds NYU Langone Health to CLARITY Trial Network. Aclarion Inc. announced that NYU Langone Health has joined its CLARITY Trial Network. The partnership brings the health system into 11 enrolling sites, expanding the company’s clinical trial footprint. This move could increase the pace of data collection for Aclarion’s pipeline. The announcement comes as the stock trades near its 14‑day support level.